In one instance, the health plan agreed to pay more than $10,000 for a drug to treat multiple sclerosis, a chronic nerve condition, that’s available for as little as $40 at retail pharmacies, according to the suit filed Monday in federal court in Camden, New Jersey.
The complaint alleges that J&J mismanaged the company’s prescription-drug benefits program, costing federally regulated plans and J&J workers millions of dollars due to higher payments for drugs, increased premiums, deductibles, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.